Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Bo tell it on the mountain: Thou Mayest founder reveals spirit driving his brand of business
Your spirit makes you alive — don’t ignore its voice when it speaks to you, Bo Nelson advised a captive audience gathered to hear how his entrepreneurial experience at Thou Mayest Coffee Roasters has enabled Kansas Citians to reach their highest good. Nelson read Tuesday from a personal journal he kept during a significant time…
Former ECJC exec Melissa Roberts joins Kauffman Foundation grant making team
Everyone has potential if given the right resources, said Melissa Roberts. “Everybody has great ideas if given the right education. Everybody has the potential to be an economic contributor in our society if given the right motivation and support,” she continued. These aren’t her words and values alone, Roberts said. They’re the legacy of Ewing…
Health scare forced KC’s colorful wax guru to get serious: ‘This is Crumble growing up with me’
Brandon Love is keeping his iconic, brightly-colored hair, but melting away distractions that could be holding back his already wildly successful, but evolving lifestyle brand, Crumble Co., he said. The first to go: Some of the eye-catching candle and wax product names that first caught customers’ attention because of their tongue-in-cheek innuendos and four-letter words,…
Insecure phones, devices creating largest-ever sensor grid (for China) in US homes, says Pepper cyber security report
As an industry, the state of cyber security is a “hot mess,” Scott Ford said candidly. “Frankly, its at a point where it ought to be concerning to everybody,” Ford, CEO of Pepper IoT, said in response to a new report that examines the state of the IoT space and released as part of a…